Remifentanil
- Generic Name
- Remifentanil
- Brand Names
- Ultiva
- Drug Type
- Small Molecule
- Chemical Formula
- C20H28N2O5
- CAS Number
- 132875-61-7
- Unique Ingredient Identifier
- P10582JYYK
- Background
Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid given to patients during surgery for pain relief and adjunctive to an anaesthetic. Remifentanil is a specific mu-type-opioid receptor agonist which means it reduces sympathetic nervous system tone, and causes respiratory depression and analgesia.
- Indication
For use during the induction and maintenance of general anesthesia.
- Associated Conditions
- -
- Associated Therapies
- Immediate postoperative analgesia therapy, Induction and Maintenance of General Anesthesia, Monitored anesthesia care sedation
Effects of Anesthetics on Postoperative Cognitive Function of Patients Undergoing Endovascular Repair of Aortic Aneurysm and Endovascular Treatment of Arteriosclerosis Obliterans of Lower Extremities.
- First Posted Date
- 2014-04-08
- Last Posted Date
- 2018-06-12
- Lead Sponsor
- Tao Zhang
- Target Recruit Count
- 68
- Registration Number
- NCT02107170
- Locations
- 🇨🇳
First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
Effect of Deksmedetomidine and Remifentanil in Extubation Agitation
- First Posted Date
- 2014-04-04
- Last Posted Date
- 2014-04-04
- Target Recruit Count
- 90
- Registration Number
- NCT02104297
- Locations
- 🇹🇷
Reyhan Polat, Ankara, Turkey
Conditions of Diagnostic Panendoscopy of the Upper Airway Under Propofol Remifentanil General Anesthesia
- First Posted Date
- 2014-03-20
- Last Posted Date
- 2014-03-20
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Target Recruit Count
- 256
- Registration Number
- NCT02093143
- Locations
- 🇫🇷
Centre Hospitalier Régional Universitaire, Besançon, France
🇫🇷CHRU Besançon, Besançon, France
The Effect of Analgesia Based Sedation Protocol on Brain Function of Critical Care Patients
- First Posted Date
- 2014-03-05
- Last Posted Date
- 2014-07-16
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT02078583
Remifentanil/Sufentanil for CABG+/-AVR Evaluated by Recovery, Cognitive Function, Haemodynamics and Biochemical Markers.
- Conditions
- Interventions
- First Posted Date
- 2014-02-04
- Last Posted Date
- 2015-08-13
- Lead Sponsor
- Aarhus University Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT02053818
- Locations
- 🇩🇰
Aarhus University Hospital, Aarhus N, Denmark
Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)
- First Posted Date
- 2014-01-30
- Last Posted Date
- 2017-02-01
- Lead Sponsor
- Joseph D. Tobias
- Target Recruit Count
- 38
- Registration Number
- NCT02049320
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
Effect of Butorphanol Combined With Flurbiprofen Axetil on Preventing Hyperalgesia Induced by Remifentanil in Patients
- Conditions
- Interventions
- First Posted Date
- 2014-01-23
- Last Posted Date
- 2016-01-08
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT02043366
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
Remifentanil vs Fentanyl During Cardiac Surgery and Chronic Thoracic Pain
- Conditions
- Interventions
- First Posted Date
- 2014-01-09
- Last Posted Date
- 2016-10-18
- Lead Sponsor
- St. Antonius Hospital
- Target Recruit Count
- 126
- Registration Number
- NCT02031016
- Locations
- 🇳🇱
St. Antonius Hospital, Nieuwegein, Netherlands
Remifentanil for General Anesthesia in the Context of Immaturity
- Conditions
- Interventions
- First Posted Date
- 2014-01-08
- Last Posted Date
- 2017-08-30
- Lead Sponsor
- University Hospital, Rouen
- Target Recruit Count
- 53
- Registration Number
- NCT02029898
- Locations
- 🇫🇷
CHU de Rouen, Rouen, France
Effect-site Concentration of Remifentanil for Blunting Hemodynamic Responses to Double-lumen Endobronchial Intubation
- First Posted Date
- 2013-12-04
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- Jeju National University School of Medicine
- Target Recruit Count
- 50
- Registration Number
- NCT02001285
- Locations
- 🇰🇷
Jeju National University Hospital, Jeju-si, Jeju Special Self-Governing Province, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.